ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Elanco Animal Health segment by Year
Elanco Animal Health segment — Pretax segment profit ($M) [legacy] ($M)
Eli Lilly Elanco Animal Health segment: $607M in FY2018, up 8.2% from a year earlier. No newer figure appears in the documents we track.
Latest, FY2018
607
Period ended Dec 31, 2018
Change on a year earlier
+8.2%
561 in FY2017
History
9 years
Since FY2010
Sources
5
Documents cited below
Where the FY2018 figure comes from
Source: Form 10-K (filed 2019-02-19) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Elanco Animal Health segment — Pretax segment profit ($M) [legacy] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2018 | Dec 31, 2018 | 607 | +8.2% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 561 | -15.4% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 664 | +11.0% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | 598 | -3.8% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 622 | +2.7% | Form 10-K (filed 2016-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 606 | +19.2% | Form 10-K (filed 2016-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 508 | +68.8% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 301 | +20.0% | Form 10-K (filed 2013-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 251 | – | Form 10-K (filed 2013-02-21) ↗ |
Cite this data
StockData. (2026). Eli Lilly Elanco Animal Health segment ($M), annual FY2010–FY2018 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/seg-animal-health-pretax-legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.